Thymosin Alpha 1: From Bench to Bedside (original) (raw)

Combination therapy with thymosin α1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the lewis lung carcinoma in mice

Francesca Pica, Antonio Mastino

International Journal of Cancer, 1992

View PDFchevron_right

Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application

Francesca Pica

International Journal of Immunopharmacology, 2000

View PDFchevron_right

Thymosin α1 in combination with cytokines and chemotherapy for the treatment of cancer

Francesca Pica, Antonio Mastino

International Immunopharmacology, 2003

View PDFchevron_right

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

Roberto Camerini

Journal of Clinical …, 2010

View PDFchevron_right

Thymosin α 1 potentiates interleukin 2-induced cytotoxic activity in mice

Antonio Mastino

Cellular Immunology, 1991

View PDFchevron_right

Large Randomized Study of Thymosin 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

Andrzej Mackiewicz

Journal of Clinical Oncology, 2010

View PDFchevron_right

Thymosin α1 and cancer: action on immune effector and tumor target cells

Claudia Matteucci

Annals of the New York Academy of Sciences, 2012

View PDFchevron_right

Immunopharmacology of thymosin α 1 and cytokine synergy

Paul Naylor

Annals of the New York Academy of Sciences, 2007

View PDFchevron_right

Immunopharmacology of Thymosin 1 and Cytokine Synergy

Paul Naylor

Annals of the New York Academy of Sciences, 2007

View PDFchevron_right

Combination therapy with BRMs in cancer and infectious diseases

Anna Palamara

Mechanisms of Ageing and Development, 1997

View PDFchevron_right

Preclinical studies with IRX-2 and thymosin α1 in combination therapy

Paul Naylor

Annals of the New York Academy of Sciences, 2010

View PDFchevron_right

Preclinical studies with IRX-2 and thymosin α1 in combination therapy: Preclinical studies with IRX-2 and Tα1

Paul Naylor

Annals of the New York Academy of Sciences, 2010

View PDFchevron_right

Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice

Antonio Mastino

International Journal of Immunopharmacology, 1989

View PDFchevron_right

Enhanced immune response and antitumor immunity with combinations of biological response modifiers

Antonio Mastino

PubMed, 1989

View PDFchevron_right

Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats

G. Silecchia, G Rasi, E. Spaziani

International journal of cancer. Journal international du cancer, 1994

View PDFchevron_right

Immunomodulation and therapeutic characterization of thymosin fraction five

James E Talmadge

Cancer Immunology Immunotherapy, 1984

View PDFchevron_right

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C

elisa ferri

Journal of Viral Hepatitis, 2001

View PDFchevron_right

From lab to bedside: emerging clinical applications of thymosin α1

Allan Goldstein

Expert Opinion on Biological Therapy, 2009

View PDFchevron_right

Interferon-alpha in tumor immunity and immunotherapy

Enrico Proietti

Cytokine & Growth Factor Reviews, 2002

View PDFchevron_right

Thymosin α 1 An endogenous regulator of inflammation, immunity, and tolerance

Roberta Gaziano

Annals of the New York Academy of Sciences, 2007

View PDFchevron_right

Thymosin 1: An Endogenous Regulator of Inflammation, Immunity, and Tolerance

G Rasi

Annals of the New York Academy of Sciences, 2007

View PDFchevron_right

Role of interferon regulatory factor 1 in governing T reg depletion, T h1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide

Alessandra Fragale

International Journal of Cancer

View PDFchevron_right

Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease

James E Talmadge

Journal of Cellular Biochemistry, 1988

View PDFchevron_right